Evaluation of coagulation assays versus LC-MS/MS for determinations of dabigatran concentrations in plasma

Measurement of dabigatran and rivaroxaban in primary prevention of venous thromboembolism in 106 patients, who have undergone major orthopedic surgery: an observational study

(2013) Meyer Michel Samama et al.   JOURNAL OF THROMBOSIS AND THROMBOLYSIS

Plasma-Diluted Thrombin Time to Measure Dabigatran Concentrations During Dabigatran Etexilate Therapy

(2012) Scott T. Avecilla et al.   AMERICAN JOURNAL OF CLINICAL PATHOLOGY

Effects on routine coagulation screens and assessment of anticoagulant intensity in patients taking oral dabigatran or rivaroxaban: Guidance from the British Committee for Standards in Haematology

(2012) Trevor Baglin et al.   BRITISH JOURNAL OF HAEMATOLOGY

The Laboratory and the New Oral Anticoagulants

(2012) A. Tripodi   CLINICAL CHEMISTRY

Laboratory assessment of the anticoagulant effects of the next generation of oral anticoagulants

(2012) D. GARCIA et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Life-threatening bleeding in four patients with an unusual excessive response to dabigatran: Implications for emergency surgery and resuscitation

(2012) Martine Wolf et al.   THROMBOSIS AND HAEMOSTASIS

Impact of dabigatran on a large panel of routine or specific coagulation assays

(2012) Séverine Robert et al.   THROMBOSIS AND HAEMOSTASIS

Reversal of Rivaroxaban and Dabigatran by Prothrombin Complex Concentrate

(2011) Elise S. Eerenberg et al.   CIRCULATION

Bleeding risk and reversal strategies for old and new anticoagulants and antiplatelet agents

(2011) M. LEVI et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Coagulation parameters in patients receiving dabigatran etexilate or rivaroxaban: Two observational studies in patients undergoing total hip or total knee replacement

(2011) Geneviève Freyburger et al.   THROMBOSIS RESEARCH

Dabigatran etexilate – a novel, reversible, oral direct thrombin inhibitor: Interpretation of coagulation assays and reversal of anticoagulant activity

(2010) Joachim Stangier et al.   THROMBOSIS AND HAEMOSTASIS

Effects of the oral, direct thrombin inhibitor dabigatran on five common coagulation assays

(2010) Fariba Baghaei et al.   THROMBOSIS AND HAEMOSTASIS

Pharmacology, Pharmacokinetics, and Pharmacodynamics of Dabigatran Etexilate, an Oral Direct Thrombin Inhibitor

(2009) Joachim Stangier et al.   CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS

Clinical Pharmacokinetics and Pharmacodynamics of the Oral Direct Thrombin??Inhibitor Dabigatran Etexilate

(2008) Joachim Stangier   CLINICAL PHARMACOKINETICS